Cognitive screening for lung cancer patients
Part of Cancer, Lungs & breathing clinical trials.
This study is testing a simple thinking and memory check for people with lung cancer. The goal is to find out how common cognitive problems are and to help doctors better support patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have small cell or non-small cell lung cancer (any stage).
- You are between 18 and 69 years old.
- You can speak and read the local language fluently.
- Your cancer has not spread to your brain (no brain metastases).
- You do not have other neurological or psychiatric conditions.
- You are not currently receiving radiation to your brain.
- You have not been diagnosed with lung cancer before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a phone-based cognitive screening can effectively assess thinking and memory. It may help people who can't easily visit a clinic.
This study measures thinking and memory skills in women who finished breast cancer treatment. Researchers want to understand how cancer treatment affects the brain and develop better support for survivors.
This study looks at how lung cancer and its treatments may affect thinking and memory. You will fill out questionnaires on your phone, tablet, or computer at home.
This study uses neurocognitive tests to check thinking and memory skills in people newly diagnosed with certain brain tumors. It aims to understand how these tumors affect the brain before treatment begins.
This trial uses special markers in the blood to find lung cancer early and track if it comes back after treatment. It is for people with non-small cell lung cancer who are able to have surgery.
This trial looks at whether doing an MRI scan of the brain for people with stage IV lung cancer helps in their care. The goal is to find brain issues early (if present) so treatment decisions can be made sooner.
Hear when a new Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.